Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

MAR-QUETIAPINE

MARCAN PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MAR-QUETIAPINE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MAR-QUETIAPINE 100MG has been permanently discontinued (last updated March 31, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Guide

Why Psychiatric Medications Keep Going Into Shortage in Canada

Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusPermanently Discontinued
Same-ingredient products on file6 products · 0 same form & route
Affected strength100MG
Report last updated2019-03-31
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SEROQUEL

CHEPLAPHARM ARZNEIMITTEL GMBH

100MG · DIN 02236952

Same strengthDifferent dosage formSame routeNo current shortage

MINT-QUETIAPINE

MINT PHARMACEUTICALS INC

300MG · DIN 02438054

Different strengthDifferent dosage formSame routeNo current shortage

PRO-QUETIAPINE

PRO DOC LIMITEE

200MG · DIN 02317362

Different strengthDifferent dosage formSame routeNo current shortage

QUETIAPINE

SANIS HEALTH INC

300MG · DIN 02353202

Different strengthDifferent dosage formSame routeNo current shortage

RIVA-QUETIAPINE

LABORATOIRE RIVA INC.

200MG · DIN 02316722

Different strengthDifferent dosage formSame routeNo current shortage

SANDOZ QUETIAPINE XRT

SANDOZ CANADA INCORPORATED

300MG · DIN 02407728

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02399830

Strength

100MG

Dosage Form

TABLET (IMMEDIATE RELEASE)

Route

ORAL

Active Ingredient

QUETIAPINE

See all QUETIAPINE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History